Agilent Acquires Biocius, Lab901 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Agilent Technologies separately announced today and yesterday that has acquired Biocius Life Sciences and Lab901.

Financial and other terms of the deals were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.